Macular Degeneration: all 1,490 studies
Page 15 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.
- Treatment of Patients With Age-Related Macular Degeneration With Anecortave AcetateNo longer availableNCT00349739
- Prophylactic Laser Treatment of Drusen MaculopathyCompletedNCT00348543Not applicable
- Photodynamic Therapy (PDT) Versus Transpupillary Thermotherapy (TTT) in Occult Choroidal Neovascularization (CNV) in Age-related Macular Degeneration (AMD)TerminatedNCT00347906Not applicable
- Optical Coherence Tomography Imaging of the Posterior Segment in High Myopia.CompletedNCT00347451
- Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular DegenerationTerminatedNCT00347399Phase 2
- Intravitreal Bevacizumab for Age-Related Macular DegenerationTerminatedNCT00347165Phase 2
- Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular DystrophyCompletedNCT00346853Phase 1
- Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.CompletedNCT00346060Phase 2
- Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous MaculopathyStatus unknownNCT00344617Phase 3
- Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)CompletedNCT00344227Phase 2
- Tracking Optical Coherence TomographyCompletedNCT00343603
- Investigating Age-Related Macular DegenerationCompletedNCT00342251
- A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular DegenerationTerminatedNCT00333476Phase 2
- PDT Study for Exudative AMD With PCVCompletedNCT00331435Phase 4
- Treatment of Patients With Neovascular AMD Using Indocyanine Green-Mediated Photothrombosis (i-MP).Status unknownNCT00331253Phase 2
- Detection of Topographic Residual Acuity in Patients With Age Related Macular DegenerationCompletedNCT00329277Not applicable
- A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.CompletedNCT00321997Phase 2/3
- Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMDCompletedNCT00320775Phase 1
- A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)TerminatedNCT00312351Phase 4
- A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein OcclusionCompletedNCT00308477Phase 1/2
- Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)CompletedNCT00305630Phase 2/3
- Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)CompletedNCT00299507Phase 3
- Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular DegenerationCompletedNCT00288561Phase 2
- Ultrasonic Evaluation of Ocular TissuesStatus unknownNCT00279695
- High-Resolution Ultrasound Imaging of the Retina and Choroid for Detection on Age Related Macular DegenerationCompletedNCT00277784
- TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular DegenerationStatus unknownNCT00260403Phase 2/3
- Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular DegenerationCompletedNCT00259753Phase 2
- A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)CompletedNCT00251459Phase 3
- Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)CompletedNCT00215670Phase 2/3
- Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.CompletedNCT00211484Phase 2
- Treatment of Age-Related Macular Degeneration With Anecortave AcetateCompletedNCT00211458Phase 2
- Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)CompletedNCT00211419Phase 1
- Pneumatic Displacement of Subretinal Hemorrhage With Perfluorocarbon GasesStatus unknownNCT00161525Phase 2
- Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular DegenerationStatus unknownNCT00157976Phase 3
- Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)CompletedNCT00150202Phase 3
- Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.Status unknownNCT00148551Phase 2/3
- Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular DegenerationCompletedNCT00140803Phase 2
- A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular DegenerationTerminatedNCT00139282Phase 3
- Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)CompletedNCT00138632Phase 1/2
- Photodynamic Therapy in Occult-Only Lesions (POOL)CompletedNCT00135837Phase 4
- Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)TerminatedNCT00134667Phase 4
- Measuring Reading Rehabilitation OutcomesCompletedNCT00125632Not applicable
- Intravitreal Microplasmin in Patients Undergoing Surgical VitrectomyCompletedNCT00123279Phase 2
- Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60CompletedNCT00121589Phase 1
- Visudyne® in Occult (VIO)CompletedNCT00121407Phase 3
- Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)CompletedNCT00109499Phase 1
- Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular DiseaseTerminatedNCT00102115Phase 1
- Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal DisordersCompletedNCT00101764Phase 1
- Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy SystemStatus unknownNCT00100087Phase 1/2
- Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular DegenerationCompletedNCT00100009Phase 3
- Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)CompletedNCT00095433Phase 3
- MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD)TerminatedNCT00094120Phase 2
- A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)CompletedNCT00090623Phase 3
- A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular DegenerationTerminatedNCT00090532Phase 1/2
- A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular DegenerationTerminatedNCT00089830Phase 2
- Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)CompletedNCT00088192Not applicable
- Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)CompletedNCT00087763Phase 2
- Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)Status unknownNCT00078221Phase 3
- Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel DisordersCompletedNCT00071227Phase 1
- Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMDTerminatedNCT00065728Phase 3
- A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular DegenerationCompletedNCT00061594Phase 3
- Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular DystrophyCompletedNCT00060749Phase 1
- An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMDCompletedNCT00058994Phase 3
- Genetic Factors in Age-Related Macular DegenerationTerminatedNCT00058695
- A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular DegenerationCompletedNCT00056836Phase 3
- Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)CompletedNCT00056823Phase 1/2
- Clinical and Genetic Studies of X-Linked Juvenile RetinoschisisCompletedNCT00055029
- Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)CompletedNCT00051129Phase 3
- Laser and Medical Treatment of Diabetic Macular EdemaCompletedNCT00050479Phase 3
- Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic TherapyCompletedNCT00043680Phase 2
- Preventing Depression in Patients With Macular DegenerationCompletedNCT00042211Phase 3
- Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMDCompletedNCT00041483Phase 3
- Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye StudyCompletedNCT00041444
- A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular DegenerationStatus unknownNCT00032396Phase 2
- Phase II/III Study of Anti-VEGF in Neovascular AMDCompletedNCT00021736Phase 2/3
- Identification and Treatment of Feeder Vessels in Macular DegenerationCompletedNCT00018070Phase 1
- Fluocinolone Implant to Treat Macular DegenerationCompletedNCT00008515Phase 1
- Lutein for Age-Related Macular DegenerationCompletedNCT00006202Phase 2
- Screening for Studies on Retinovascular DiseasesCompletedNCT00001733
- Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular DegenerationCompletedNCT00001615Phase 1
- Long Term Follow-Up of Diabetic RetinopathyCompletedNCT00001395
- Diabetic Retinopathy and Visual Function StudyCompletedNCT00001346
- Tissue Studies of Human Eye DiseasesTerminatedNCT00001310
- Complications of Age-Related Macular Degeneration Prevention TrialCompletedNCT00000167Phase 3
- Branch Vein Occlusion StudyCompletedNCT00000162Phase 3
- Randomized Trials of Vitamin Supplements and Eye DiseaseStatus unknownNCT00000161Phase 3
- Macular Photocoagulation Study (MPS)Status unknownNCT00000158Phase 3
- Randomized Trial of Beta-Carotene and Macular DegenerationStatus unknownNCT00000152Phase 3
- Submacular Surgery Trials (SST)CompletedNCT00000150Phase 3
- Age-Related Eye Disease Study (AREDS)CompletedNCT00000145Phase 3